AAAAAA
Results: 126-150/860
Authors:
Kleihues, P
Ohgaki, H
Citation: P. Kleihues et H. Ohgaki, Phenotype vs genotype in the evolution of astrocytic brain tumors, TOX PATHOL, 28(1), 2000, pp. 164-170
Authors:
Holland, EC
Citation: Ec. Holland, A mouse model for glioma: Biology, pathology, and therapeutic opportunities, TOX PATHOL, 28(1), 2000, pp. 171-177
Authors:
Krinke, GJ
Kaufmann, W
Mahrous, AT
Schaetti, P
Citation: Gj. Krinke et al., Morphologic characterization of spontaneous nervous system tumors in mice and rats, TOX PATHOL, 28(1), 2000, pp. 178-192
Authors:
Zook, BC
Simmens, SJ
Jones, RV
Citation: Bc. Zook et al., Evaluation of ENU-induced gliomas rats: Nomenclature, immunochemistry, andmalignancy, TOX PATHOL, 28(1), 2000, pp. 193-201
Authors:
Rice, JM
Wilbourn, JD
Citation: Jm. Rice et Jd. Wilbourn, Tumors of the nervous system in carcinogenic hazard identification, TOX PATHOL, 28(1), 2000, pp. 202-214
Authors:
Richardson, FC
Tennant, BC
Meyer, DJ
Richardson, KA
Mann, PC
McGinty, GR
Wolf, JL
Zack, PM
Bendele, RA
Citation: Fc. Richardson et al., An evaluation of the toxicities of 2 '-fluorouridine and 2 '-fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax), TOX PATHOL, 27(6), 1999, pp. 607-617
Authors:
Hardisty, JF
Garman, RH
Harkema, JR
Lomax, LG
Morgan, KT
Citation: Jf. Hardisty et al., Histopathology of nasal olfactory mucosa front selected inhalation toxicity studies conducted with volatile chemicals, TOX PATHOL, 27(6), 1999, pp. 618-627
Authors:
Ikeda, Y
Takahashi, S
Kimura, J
Cho, YM
Imaida, K
Shirai, S
Shirai, T
Citation: Y. Ikeda et al., Anophthalmia in litters of female rats treated with the food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, TOX PATHOL, 27(6), 1999, pp. 628-631
Authors:
Fenoglio-Preiser, CM
Noffsinger, A
Citation: Cm. Fenoglio-preiser et A. Noffsinger, Aberrant crypt foci: A review, TOX PATHOL, 27(6), 1999, pp. 632-642
Authors:
Whiteley, LO
Citation: Lo. Whiteley, Colonic mucosal aberrant crypt foci: Are they useful intermediate endpoints for predicting and understanding the development of colonic mucosal neoplasia?, TOX PATHOL, 27(6), 1999, pp. 643-644
Authors:
Ogawa, K
St John, M
de Oliveira, ML
Arnold, L
Shirai, T
Sun, TT
Cohen, SM
Citation: K. Ogawa et al., Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice, TOX PATHOL, 27(6), 1999, pp. 645-651
Authors:
Toussaint, MW
Wolfe, MJ
Burton, DT
Hoffmann, FJ
Shedd, TR
Gardner, HS
Citation: Mw. Toussaint et al., Histopathology of Japanese medaka (Oryzias latipes) chronically exposed toa complex environmental mixture, TOX PATHOL, 27(6), 1999, pp. 652-663
Authors:
Eto, K
Takizawa, Y
Akagi, H
Haraguchi, K
Asano, S
Takahata, N
Tokunaga, H
Citation: K. Eto et al., Differential diagnosis between organic and inorganic mercury poisoning in human cases - The pathologic point of view, TOX PATHOL, 27(6), 1999, pp. 664-671
Authors:
Guzman, RE
Kerlin, RL
Zimmerman, TE
Citation: Re. Guzman et al., Histologic lesions in cynomolgus monkeys (Macaca fascicularis) naturally infected with simian retrovirus type D: Comparison of seropositive, virus-positive, and uninfected animals, TOX PATHOL, 27(6), 1999, pp. 672-677
Authors:
Pilling, AM
Citation: Am. Pilling, The role of the toxicologic pathologist in the preclinical safety evaluation of biotechnology-derived pharmaceuticals, TOX PATHOL, 27(6), 1999, pp. 678-688
Citation: XVIII International Symposium of the Society of Toxicologic Pathologists -Meeting Abstracts: "Toxicologic Pathology of the Nervous System", TOX PATHOL, 27(6), 1999, pp. 690-704
Authors:
Trump, BF
Citation: Bf. Trump, Mechanisms of toxicity, carcinogenesis, and cancer prevention, TOX PATHOL, 27(6), 1999, pp. 705-706
Authors:
Hunter, T
Citation: T. Hunter, Keynote presentation: Cancer research and therapy in the new millennium, TOX PATHOL, 27(6), 1999, pp. 708-734
Authors:
Holden, HE
Studwell, D
Majeska, JB
Citation: He. Holden et al., Oxymetholone: I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays, TOX PATHOL, 27(5), 1999, pp. 501-506
Authors:
Holden, HE
Stoll, RE
Blanchard, KT
Citation: He. Holden et al., Oxymetholone: II. Evaluation in the Tg.AC transgenic mouse model for detection of carcinogens, TOX PATHOL, 27(5), 1999, pp. 507-512
Authors:
Stoll, RE
Holden, HE
Barthel, CH
Blanchard, KT
Citation: Re. Stoll et al., Oxymetholone: III. Evaluation in the p53(+/-) transgenic mouse model, TOX PATHOL, 27(5), 1999, pp. 513-518
Authors:
Alden
Citation: Alden, Pathologist and toxicologist in pharmaceutical product discovery (vol 27, pg 104, 1999), TOX PATHOL, 27(5), 1999, pp. 518-518
Authors:
Blanchard, KT
Barthel, C
French, JE
Holden, HE
Moretz, R
Pack, FD
Tennant, RW
Stoll, RE
Citation: Kt. Blanchard et al., Transponder-induced sarcoma in the heterozygous p53(+/-) mouse, TOX PATHOL, 27(5), 1999, pp. 519-527
Authors:
Kimura, T
Doi, K
Citation: T. Kimura et K. Doi, Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids, TOX PATHOL, 27(5), 1999, pp. 528-535
Authors:
Mordenti, J
Cuthbertson, RA
Ferrara, N
Thomsen, K
Berleau, L
Licko, V
Allen, PC
Valverde, CR
Meng, YG
Fei, DTW
Fourre, KM
Ryan, AM
Citation: J. Mordenti et al., Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of I-125-labeled full-length and Fab antibodies in rhesus monkeys following lntravitreal administration, TOX PATHOL, 27(5), 1999, pp. 536-544